SubscribeLogin
News-Medical.net image

News from News-Medical.net

If you want to know if News-Medical.net is credible or reliable, look no further. We rank News-Medical.net as Unknown factuality. Find out more about our methodology here.

Information about News-Medical.net

Where is News-Medical.net located?News-Medical.net's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top News-Medical.net News

Brain cells mature faster in space but stay healthy: ISS study
Environment

Brain cells mature faster in space but stay healthy: ISS study

100% Center coverage: 4 sources
Microgravity is known to alter the muscles, bones, the immune system and cognition, but little is known about its specific impact on the brain. To discover how brain cells respond to microgravity, Scripps Research scientists, in collaboration with the New York Stem Cell Foundation, sent tiny clumps of stem-cell derived brain cells called "organoids" to the International Space Station (ISS).See the Story
Scientists find vulnerability in antibiotic resistance mechanism
Environment · Dresden

Scientists find vulnerability in antibiotic resistance mechanism

100% Center coverage: 3 sources
Superbugs, bacteria that are immune to multiple antibiotics, pose a great challenge to modern medicine. Researchers from the B CUBE—Center for Molecular Bioengineering at TUD Dresden University of Technology and Institut Pasteur in Paris identified a weakness in the bacterial machinery that drives antibiotic resistance adaptation. Their findings, published in the journal Science Advances, could pave the way to boosting the effectiveness of exist…See the Story
Gates Foundation to invest up to $50M in Somerville biotech’s sickle-cell medicines
Business

Gates Foundation to invest up to $50M in Somerville biotech’s sickle-cell medicines

100% Center coverage: 2 sources
Two Massachusetts companies already won approval for ex-vivo gene therapies to treat sickle cell disease. But, patients receiving these treatments have to undergo high-dose chemotherapy. A Somerville biotech thinks its in-vivo genetic medicines could avoid these challenges.See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal